GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc., 3D Systems Corporation and AVANIR Pharmaceuticals

May 20, 2013 | About:
alicet236

alicet236

6 followers
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Danaher Corporation, Orbitz Worldwide Inc., 3D Systems Corporation and AVANIR Pharmaceuticals.



Danaher Corporation (DHR): President and CEO H. Lawrence Culp Jr. Sold 500,000 Shares


President and CEO of Danaher Corporation (DHR) H. Lawrence Culp Jr. sold 500,000 shares on 05/15/2013 at an average price of $61.92. Danaher Corporation, originally DMG Inc., was organized in 1969 as a Massachusetts real estate investment trust. Danaher Corporation has a market cap of $43.13 billion; its shares were traded at around $63.25 with a P/E ratio of 18.21 and P/S ratio of 2.45. The dividend yield of Danaher Corporation stocks is 0.16%. Danaher Corporation had an annual average earnings growth of 13.5% over the past 10 years. GuruFocus rated Danaher Corporation the business predictability rank of 4-star.

Danaher Corporation reported their 2013 first financial quarter results. The company reported net earnings of $691.9 million and revenues of $4.4 billion.

President and CEO H. Lawrence Culp Jr. sold 628,000 shares of DHR stock in February and May. Executive Vice President and CFO Daniel L. Comas sold 90,460 shares of DHR stock on 01/31/2013 at the average price of $60.31. Director Walter G. Lohr, Executive Vice President James A. Lico and Executive Vice President Thomas Patrick Joyce Jr. sold 116,242 shares of DHR stock on in February, April and May.

Orbitz Worldwide Inc. (OWW): CEO Barney Harford Sold 519,812 Shares

CEO of Orbitz Worldwide Inc. (OWW) Barney Harford sold 519,812 shares during the past week at an average price of $7.68. Orbitz Worldwide Inc. was incorporated in Delaware on June 18, 2007. Orbitz Worldwide Inc. has a market cap of $775.09 million; its shares were traded at around $7.44 with a P/E ratio of 41.70 and P/S ratio of 1.01.

Orbitz Worldwide Inc reported net sales of $202.9 million and net income of $146.2 million for their 2013 first quarter results.

CEO Barney Harford sold 719,512 shares of OWW stock in April and May. GVP, Chief Accounting Officer Thomas L. Kram, President Orbitz & Cheaptickets Christopher Orton and Senior Vice President Global Product Strategy Samuel M. Fulton sold 13,620 shares of OWW stock in March, April and May.

3D Systems Corporation (DDD): President and CEO Abraham N. Reichental Sold 400,000 Shares

President and CEO of 3D Systems Corporation (DDD) Abraham N. Reichental sold 400,000 shares on 05/15/2013 at an average price of $40. 3D Systems Corporation is a holding company that operates through its subsidiaries in the United States, Europe and the Asia-Pacific region. 3d Systems Corporation has a market cap of $4.24 billion; its shares were traded at around $46.66 with a P/E ratio of 69.93 and P/S ratio of 10.78. 3d Systems Corporation had an annual average earnings growth of 159.2% over the past 5 years.

3D Systems Corporation reported that their 2013 first quarter revenues increased by 31% from last year’s first quarter to 102.1 million and GAAP net income of $5.9 million.

President and CEO Abraham N. Reichental sold 400,000 shares of DDD stock on 05/15/2013 at the average price of $40. Senior Vice President and CFO Damon Joseph Gregoire sold 45,000 shares of DDD stock on 05/15/2013 at the average price of $40. Director Riper Daniel S. Van, Director Jim D. Kever, and Director G. Walter Loewenbaum II, sold 880,613 shares of DDD stock in March and May.

AVANIR Pharmaceuticals (AVNR): President and CEO Keith Katkin Sold 250,438 Shares

President and CEO of AVANIR Pharmaceuticals (AVNR) Keith Katkin sold 250,438 shares on 05/15/2013 at an average price of $3.26. Avanir Pharmaceuticals Inc. was incorporated in California in August 1988 and was reincorporated in Delaware in March 2009. Avanir Pharmaceuticals has a market cap of $478.861 million; its shares were traded at around $3.32 with and P/S ratio of 7.72. Avanir Pharmaceuticals had an annual average earnings growth of 11.2% over the past five years.

AVANIR Pharmaceuticals reported their fiscal second quarter results with revenues of $17.4 million and net loss of $16.5 million.

President and CEO Keith Katkin sold 268,688 shares of AVNR stock in December and May. Senior Vice President and Chief Commercial Officer Rohan Palekar bought 10,000 shares of AVNR stock on 12/13/2012 at the average price of $2.46. Vice President Finance Christine Ocampo sold 80,545 shares of AVNR stock in December and May.

For the complete list of stocks that were bought by their CEOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK